Nuvisan
A CRO That Supports Science
Since 1979, Nuvisan has been offering a range of services supporting the pharmaceutical industry to include drug discovery, Good Laboratory Practice (GLP) bioanalysis, pharmaceutical analytics, clinical trial supplies, and more.
Nuvisan’s bioanalytical services provide flexibility and expertise for projects covering discovery through late-stage clinical trials, with LC-MS/MS and immunoassay capabilities at four locations in Europe.
Through routine inspections by European (EMA), USA (FDA), and Brazilian (ANVISA) regulatory authorities, Nuvisan can assure quality in support of your filing. Recently, Nuvisan has also been inspected by the WHO.
Microsampling MD/MV as well as sample analysis has been employed on numerous occasions in support of single-center and multi-center clinical trials.
- Small Molecules
- Biomarkers
- Proprietary Compounds
Nuvisan is GLP certified as well as FDA, EMA, ANVISA, and WHO inspected.
Nuvisan has locations in both Europe and South America, while providing our services globally.